In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance Industries Limited, has been granted an Indian patent for an integrated platform that uses artificial intelligence (AI) and cell-free DNA (cfDNA) analysis to detect cancer from a simple blood sample. The patented technology combines high-quality genome sequencing, …










